BioPharm Business News and Perspectives

Thursday, May 12, 2011 Horizon Pharma Announces the FDA Approval of Duexis (Ibuprofen/Famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper GI Ulcers
Duexis is a novel tablet formulation containing a fixed-dose combination of ibuprofen and famotidine...

Thursday, April 28, 2011 NicOx Withdraws Its Marketing Authorization Application for Naproxcinod in Europe
NicOx originally submitted the naproxcinod MAA to the European Medicines Agency (EMA) in December 2009...

Monday, April 25, 2011 Actemra (tocilizumab) Approved for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
Actemra can be administered alone or in combination with methotrexate in patients with SJIA...

Tuesday, April 27, 2010 DePuy Spine Launches Expedium Vertebral Body Derotation Instrument Set
The set is designed to help surgeons correct spinal alignment and decrease rib rotation in patients with scoliosis...

Wednesday, April 21, 2010 GSK and Human Genome's Lupus Drug Fails to Meet Secondary Endpoint in Phase III Trial
Effects of the lupus drug Benlysta (belimumab) appear to wane over time...

Wednesday, April 07, 2010 Pfizer Predicts "Golden Age of Drug Discovery"
Pfizer is working on drugs to treat pain, inflammation, cancer, and Alzheimer's disease, some of which they predict will be mega sellers...

Monday, March 15, 2010 Roche Suspends Experimental Arthritis Drug Study
Risks were found to outweigh potential benefits in the study of ocrelizumab after cases of serious infections led to several deaths...

Thursday, March 11, 2010 AstraZeneca in a Deal with Torrent Pharmaceuticals to Market Generics
The UK drugmaker will market 18 of Torrent's drugs in 9 emerging economies, marking AstraZeneca's first generic-drug partnership...

Wednesday, February 17, 2010 AstraZeneca to Enter the RA Market
AstraZeneca is entering the rheumatoid arthritis (RA) market by gaining rights to Rigel’s RA drug...

Thursday, February 11, 2010 Merck Settles Vioxx Lawsuits
Merck & Co. has agreed to settle lawsuits over their withdrawn painkiller Vioxx with a strengthening of safety procedures, change of leadership, and payment of legal fees...